Study of ANX007 in Participants With Primary Open-angle Glaucoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a double-masked, randomized, sham-controlled study evaluating two dose levels of ANX007 vs sham, administered as repeat Intravitreal (IVT) injections in patients with Primary Open-angle Glaucoma.
Epistemonikos ID: ba384783dd9ff4def6334f52b97ae7e72381c97a
First added on: May 06, 2024